Association of colon cancer (CC) molecular signatures with prognosis and oxaliplatin prediction benefit in the MOSAIC Trial (Multicenter International Study of Oxaliplatin/5FU-LV in the Adjuvant Treatment of Colon Cancer).

Authors: Pogue-Geile, K.L., Hickish, T. et al.

Journal: JOURNAL OF CLINICAL ONCOLOGY

Volume: 37

Issue: 15

eISSN: 1527-7755

ISSN: 0732-183X

DOI: 10.1200/JCO.2019.37.15_suppl.3503

Source: Web of Science (Lite)